Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Sodium benzoate

EU orphan designation number: EU/3/16/1729   
Active ingredient: Sodium benzoate
Indication: Treatment of lysinuric protein intolerance
Sponsor: Lucane Pharma SA
172 rue de Charonne, 75011 Paris, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
31/08/2016 Orphan designation EMA/OD/055/16 (2016)5636 of 29/08/2016